|
1
|
Jemal A, Siegel R, Ward E, Murray T, Xu J
and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin. 57:43–66.
2007. View Article : Google Scholar
|
|
2
|
Petrylak DP: The current role of
chemotherapy in metastatic hormone-refractory prostate cancer.
Urology. 65:3–8. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chandrika PM, Yakaiah T, Rao AR, et al:
Synthesis of novel 4,6-disubstituted quinazoline derivatives, their
anti-inflammatory and anti-cancer activity (cytotoxic) against U937
leukemia cell lines. Eur J Med Chem. 43:846–852. 2008. View Article : Google Scholar
|
|
4
|
Chen Z, Huang X, Yang H, et al: Anti-tumor
effects of B-2, a novel 2,3-disubstituted
8-arylamino-3H-imidazo[4,5-g]quinazoline derivative, on the human
lung adenocarcinoma A549 cell line in vitro and in vivo. Chem Biol
Interact. 189:90–99. 2011.PubMed/NCBI
|
|
5
|
Yang JS, Hour MJ, Huang WW, Lin KL, Kuo SC
and Chung JG: MJ-29 inhibits tubulin polymerization, induces
mitotic arrest, and triggers apoptosis via cyclin-dependent kinase
1-mediated Bcl-2 phosphorylation in human leukemia U937 cells. J
Pharmacol Exp Ther. 334:477–488. 2010. View Article : Google Scholar
|
|
6
|
Chen KT, Hour MJ, Tsai SC, et al: The
novel synthesized
6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10)
compound exhibits anti-metastatic effects in human osteosarcoma U-2
OS cells through targeting insulin-like growth factor-I receptor.
Int J Oncol. 39:611–619. 2011.
|
|
7
|
Liu KC, Huang AC, Wu PP, et al: Gallic
acid suppresses the migration and invasion of PC-3 human prostate
cancer cells via inhibition of matrix metalloproteinase-2 and -9
signaling pathways. Oncol Rep. 26:177–184. 2011.PubMed/NCBI
|
|
8
|
Ma CY, Ji WT, Chueh FS, et al: Butein
inhibits the migration and invasion of SK-HEP-1 human
hepatocarcinoma cells through suppressing the ERK, JNK, p38, and
uPA signaling multiple pathways. J Agric Food Chem. 59:9032–9038.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lan YH, Wu YC, Wu KW, et al: Death
receptor 5-mediated TNFR family signaling pathways modulate
gamma-humulene-induced apoptosis in human colorectal cancer HT29
cells. Oncol Rep. 25:419–424. 2011.PubMed/NCBI
|
|
10
|
Huang WW, Ko SW, Tsai HY, et al:
Cantharidin induces G2/M phase arrest and apoptosis in human
colorectal cancer colo 205 cells through inhibition of CDK1
activity and caspase-dependent signaling pathways. Int J Oncol.
38:1067–1073. 2011.
|
|
11
|
Yu FS, Yang JS, Yu CS, et al: Safrole
induces apoptosis in human oral cancer HSC-3 cells. J Dent Res.
90:168–174. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu CC, Yang JS, Huang AC, et al:
Chrysophanol induces necrosis through the production of ROS and
alteration of ATP levels in J5 human liver cancer cells. Mol Nutr
Food Res. 54:967–976. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chiang JH, Yang JS, Ma CY, et al:
Danthron, an anthraquinone derivative, induces DNA damage and
caspase cascades-mediated apoptosis in SNU-1 human gastric cancer
cells through mitochondrial permeability transition pores and
Bax-triggered pathways. Chem Res Toxicol. 24:20–29. 2011.
View Article : Google Scholar
|
|
14
|
Huang WW, Chiu YJ, Fan MJ, et al:
Kaempferol induced apoptosis via endoplasmic reticulum stress and
mitochondria-dependent pathway in human osteosarcoma U-2 OS cells.
Mol Nutr Food Res. 54:1585–1595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Danthron. Rep Carcinog. 12:128–129.
2011.
|
|
16
|
Lo C, Lai TY, Yang JS, et al: Gallic acid
inhibits the migration and invasion of A375.S2 human melanoma cells
through the inhibition of matrix metalloproteinase-2 and Ras.
Melanoma Res. 21:267–273. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kuo TC, Yang JS, Lin MW, et al: Emodin has
cytotoxic and protective effects in rat C6 glioma cells: roles of
Mdr1a and nuclear factor kappaB in cell survival. J Pharmacol Exp
Ther. 330:736–744. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang SW, Pan SL, Huang YC, et al: CHM-1, a
novel synthetic quinolone with potent and selective antimitotic
antitumor activity against human hepatocellular carcinoma in vitro
and in vivo. Mol Cancer Ther. 7:350–360. 2008. View Article : Google Scholar
|
|
19
|
Hsu SC, Yang JS, Kuo CL, et al: Novel
quinolone CHM-1 induces apoptosis and inhibits metastasis in a
human osterogenic sarcoma cell line. J Orthop Res. 12:1637–1644.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gondi CS and Rao JS: Therapeutic potential
of siRNA-mediated targeting of urokinase plasminogen activator, its
receptor, and matrix metalloproteinases. Methods Mol Biol.
487:267–281. 2009.PubMed/NCBI
|
|
21
|
Chen PN, Hsieh YS, Chiou HL and Chu SC:
Silibinin inhibits cell invasion through inactivation of both
PI3K-Akt and MAPK signaling pathways. Chem Biol Interact.
156:141–150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Westermarck J and Kahari VM: Regulation of
matrix metalloproteinase expression in tumor invasion. FASEB J.
13:781–792. 1999.PubMed/NCBI
|
|
23
|
Aguirre Ghiso JA, Alonso DF, Farias EF,
Gomez DE and de Kier Joffe EB: Deregulation of the signaling
pathways controlling urokinase production. Its relationship with
the invasive phenotype. Eur J Biochem. 263:295–304. 1999.PubMed/NCBI
|
|
24
|
Peng PL, Hsieh YS, Wang CJ, Hsu JL and
Chou FP: Inhibitory effect of berberine on the invasion of human
lung cancer cells via decreased productions of
urokinase-plasminogen activator and matrix metalloproteinase-2.
Toxicol Appl Pharmacol. 214:8–15. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar
|
|
26
|
Lin YT, Yang JS, Lin HJ, et al: Baicalein
induces apoptosis in SCC-4 human tongue cancer cells via a
Ca2+-dependent mitochondrial pathway. In Vivo.
21:1053–1058. 2007.PubMed/NCBI
|
|
27
|
Chuang JY, Huang YF, Lu HF, et al:
Coumarin induces cell cycle arrest and apoptosis in human cervical
cancer HeLa cells through a mitochondria- and caspase-3 dependent
mechanism and NF-kappaB down-regulation. In Vivo. 21:1003–1009.
2007.PubMed/NCBI
|
|
28
|
Huang YT, Hwang JJ, Lee LT, et al:
Inhibitory effects of a luteinizing hormone-releasing hormone
agonist on basal and epidermal growth factor-induced cell
proliferation and metastasis-associated properties in human
epidermoid carcinoma A431 cells. Int J Cancer. 99:505–513. 2002.
View Article : Google Scholar
|
